// App-Quantinova.ai

: Management of Anticoagulant Therapy around Delivery: Results from the Ongoing Highlow Study

Researchers

Presenter

  • I. Bistervels

Principal Investigators

  • A. Buchmller

  • F. N Anle

  • S. Bleker

  • C. Chauleur

  • J. Donnelly

  • A.F. Jacobsen

  • M. Rodger

  • M. DeSancho

  • P. Verhamme

  • S. Middeldorp

Medical Centers

  • Amsterdam UMC, University of Amsterdam, Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands

  • - F Crin, INNOVTE, CHU Saint-Etienne, Hopital Nord, Service Medecine Vasculaire et Therapeutique, Saint-Etienne, Saint Etienne, France

  • Mater Misericordiae University Hospital and Rotunda Hospital, Department of Hematology, Dublin, Ireland

  • SPHERE Research Group, University College Dublin School of Medicine, Dublin, Ireland

  • CHU Saint-Etienne, Hopital Nord, Service de Gyneco-Obstetrique, Saint Etienne, France

  • Mater Misericordiae University Hospital and Rotunda Hospital, Department of Hematology, Dublin, Ireland

  • Akershus University Hospital, Department of Obstetrics and Gynaecology, Lorenskog, Norway

  • The Ottawa Hospital, Department of Hematology, Ottawa, Canada

  • Weill Cornell Medicine, New York Presbyterian Hospital, Division of Hematology‐Oncology, Department of Medicine, New York, United States

  • KU Leuven, Center for Molecular and Vascular Biology, Leuven, Belgium

Locations

  • Netherlands

  • France

  • Ireland

  • Norway

  • Canada

  • United States

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Multinational

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A